Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ING Groep NV (ING) vs Stryker Corporation (SYK) Price & Performance

ING Groep NVTrade
Stryker CorporationTrade

Price performance (Past 24H)

Key statistics

ING Groep NV vs Stryker Corporation — how do they compare? ING Groep NV trades at $33.36 (market cap $93.76B), while Stryker Corporation trades at $277.34 (market cap $106.24B). The key difference: ING Groep NV and Stryker Corporation are close in size by market cap, and ING Groep NV pays the higher dividend (3.95%). Which is the better fit depends on your goals — on Pluang, investors hold ING Groep NV for 94 Days and Stryker Corporation for 21 Days on average.

INGSYK
Market Cap
$93.76B$106.24B
Volume
4,620,2202,982,001
Sector
FinancialsHealth
52-Week High
$37.27$388.35
52-Week Low
$23.66$269.75
Typical Hold Time
94 Days21 Days
Enterprise Value
$236.48B$117.70B
Dividend Yield
3.95%1.27%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ING Groep NV

ING stock trades at $33.28, down 1.89% today, with bearish technical signals despite strong fundamentals. The company has beaten earnings estimates for three consecutive quarters, maintains a 28.34% net income margin, and analysts show strong support with 11 buy ratings versus no sell ratings. Recent news highlights management's raised ROE target above 16% for 2027 and strategic focus on organic growth.

The investment case balances solid profitability and analyst optimism against technical weakness and cash flow challenges. Upside potential exists from earnings momentum and strategic initiatives, while risks include persistent negative operating cash flows and regulatory scrutiny in international markets.

Stryker Corporation

Stryker (SYK) trades at $277.52, up 0.77% today, amid a mixed technical and fundamental backdrop. The stock shows a bearish technical signal with key support at $274 and resistance at $279. Fundamentally, the company reported strong profitability with a 14.43% net income margin in 2026 and beat EPS estimates in two of the last three quarters. However, recent news highlights potential legal and manufacturing issues that have pressured investor sentiment.

The outlook is cautiously optimistic, with a consensus price target of $368.11 implying significant upside. Investment opportunities lie in SYK's robust earnings growth and market leadership in medical technology, but risks include ongoing legal investigations and persistent manufacturing challenges that could impact future performance.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ING
10% Buy90% Sell
Avg holding period · 94 Days
SYK

No sentiment data available yet.

Top news

Latest headlines on both assets

About ING Groep NV

The merger of the Dutch postal bank and NN Insurance in 1991 created ING. Through a series of further acquisitions ING build up a global footprint. The 2008 financial crisis forced ING to seek government support--a precondition of which was that ING should separate its banking and insurance activities, which saw ING revert to being solely a bank. ING has market- leading banking operations in the Netherlands and Belgium, and a range of digital banks across Europe and Australia. Its global wholesale banking operation is primarily focused on lending.

Read more on ING →

About Stryker Corporation

Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.

Read more on SYK →